H.R. 4752: Reducing Hereditary Cancer Act

H.R. 4752 is a federal bill in the 119th Congress. Currently, Medicare does not explicitly cover germline mutation testing, which identifies inherited genetic changes that increase cancer risk. This bill changes that by requiring Medicare to cover this testing for individuals who have a personal or family… See its sponsors, how members voted, and a plain-English breakdown on PolityLens.